Abstract:Stroke, Ahead of Print. BACKGROUND:Moyamoya angiopathy (MMA) is an important cause of juvenile stroke but an overall rare disease among European populations compared with East Asian cohorts. Consecutively, hemorrhagic MMA is described well in East Asian cohorts, but knowledge in non-Asian patients is limited. Literature suggests that disease presentation may vary between those cohorts, also including hemorrhage frequencies. Hence, this article aims to analyze hemorrhagic MMA in European patients.METHODS:We screened for patients of European origin with MMA from a single-center consecutive database of a German hospital specialized on MMA. Those who had a record of intracranial hemorrhage were analyzed individually regarding the type of hemorrhage and use of antiplatelet therapy before and after bleeding onset. To identify associated factors of intracranial hemorrhage, an age- and sex-matched control group was identified from the pool of patients without a history of hemorrhage. Both groups had a comparable follow-up time and were compared in terms of disease presentation, therapeutic interventions, and imaging characteristics, using both univariate tests and multivariate logistic regression analysis.RESULTS:From a pool of 332 patients with MMA we identified 288 of European ancestry. From those, 36 had a record of intracranial hemorrhage (12.5%). Thirty-three patients presenting with 37 events were included for further analysis and case-control-comparison. Most events were intracerebral hemorrhage (n=20; 54%) and subarachnoid hemorrhage (n=11; 30%). 78% developed hemorrhage although no antiplatelet therapy was in use (n=29). Seven patients developed intracranial hemorrhage ipsilateral to prior bypass surgery (21%), while 29 of the control patients had a bypass surgery (88%;P=0.0001). There was no significant difference in terms of unilateral or bilateral disease type, history of hypertension, as well as imaging characteristics (high Suzuki stage and the presence of collateral pathways in conventional angiography, as well as ischemic defects and the presence of microbleeds on cerebral magnetic resonance imaging;P>0.05 in multivariate analysis, respectively).CONCLUSIONS:Bypass surgery was negatively associated with the development of intracranial hemorrhage in MMA in European patients. There was no difference in terms of a history of hypertension between groups, indicating that blood pressure is not the major contributor for rupture of fragile collateral vessels. The investigated imaging characteristics were not associated to hemorrhage onset and, therefore, are not suitable as a tool of screening for patients at risk.

Abstract WP225: Changes in Hemoglobin Levels During Vascular Events in Moyamoya Arteriopathy

Low Hemoglobin Levels at Admission Are Independently Associated with Cognitive Impairment after Ischemic Stroke: a Multicenter, Population-Based Study

Significance of Serum Angiopoietin-2 in Patients with Hemorrhage in Adult-Onset Moyamoya Disease

Association between baseline hemoglobin level and early neurological deterioration after intravenous thrombolysis in patients with acute ischemic stroke.

Hemoglobin Drop is Associated with Early Post-operative Stroke Following Revascularization Surgery for Moyamoya Disease

Relative anemia and perioperative stroke in children with moyamoya

Abstract W P43: Extent of “blooming Effect” Predicts Middle Cerebral Artery Recanalization after Intravenous Thrombolysis

Exploring the Impact of Hemoglobin on Cerebral Blood Flow in Arterial Territories and Surgical Outcomes: Potential Implications for Moyamoya Disease Treatment

Detrimental effect of anemia after mechanical thrombectomy on functional outcome in patients with ischemic stroke

Hemorrhagic Moyamoya Angiopathy in European Patients

Anemia and Risk of Periprocedural Cerebral Injury Detected by Diffusion-Weighted Magnetic Resonance Imaging in Patients Undergoing Transcatheter Aortic Valve Replacement.

A Cohort Study of Patients with Anemia on Admission and Fatality after Acute Ischemic Stroke

Impact of anemia on acute ischemic stroke outcomes: A systematic review of the literature

Abstract WP176: Hemoglobin Decrement is Associated With Ischemic Lesions on Brain MRI of Patients With Acute Intracerebral Hemorrhage

Anemia on Admission Predicts Short- and Long-Term Outcomes in Patients with Acute Ischemic Stroke

Effects of Hemoglobin Levels on Long-Term Prognosis in Patients with Acute ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Impact of Hemoglobin Levels on Composite Cardiac Arrest or Stroke Outcome in Patients With Respiratory Failure Due to COVID-19

Correlation Analysis Between Decreased Cerebral Perfusion Measured from Arterial Spin Labeling and Cerebrovascular Events in Patients with Bilateral Moyamoya Angiography

Hemoglobin levels and cognitive trajectory: unveiling prognostic insights in post-stroke geriatric cohort

Admission Hemoglobin Is Prognostic for In-Hospital Mortality in Oldest-Old Patients with Acute Ischemic Stroke

Impact of anemia on outcomes and resource utilization in patients with myocardial infarction: A national database analysis